Comparison of Transoral and Transcutaneous Approaches for Gender-Affirming Thyroid Cartilage Reduction: A Case Series of 246 Patients

医学 四分位间距 血清瘤 外科 并发症 甲状腺 回顾性队列研究 疤痕 内科学
作者
Iris Y. Deng,Nghiem H. Nguyen,Alexander A. Argame,James C. Lee,Michael Chu
出处
期刊:Plastic and Reconstructive Surgery [Lippincott Williams & Wilkins]
标识
DOI:10.1097/prs.0000000000011961
摘要

Background: Thyroid cartilage reduction (TCR) for gender-affirming neck surgery can reduce prominent thyroid notches and improve dysphoria. TCR can be performed with a transoral or transcutaneous approach. This study aims to review TCR approaches and outcomes. Methods: A retrospective chart review of all TCRs at a multi-institutional, integrated healthcare system from May 2016 to July 2024 was performed. Patient demographics, operative details, and post-operative complications were reviewed. Major complications included invasive interventions (corticosteroid injections for scars, fluid drainage, etc) or intraoperative complications. Minor complications included infections, hypertrophic scarring, and temporary voice changes. Chi square tests and Mann-Whitney U tests were performed to evaluate differences in postoperative outcomes by surgical approach. Results: A total of 246 patients underwent TCR with 207 patients (84.1%) in the transcutaneous group and 39 patients (15.9%) in the transoral group. The median patient age was 30.7 years (interquartile range, IQR 24.9-39.0). Median BMI was 22.7 kg/m 2 (IQR 20.6-25.5). There were no significant differences between transcutaneous and transoral groups, for median age (30.1 years vs 33.4 years, p= 0.08) or median BMI (22.6 kg/m 2 vs 23.7 kg/m 2 , p= 0.28). Total major complication was 9.3% and minor complication was 10.6%. There were no significant differences between transcutaneous and transoral groups in rates of major (9.2% vs 10.3%, p= 0.83) or minor (12.1% vs 2.6%, p= 0.08) complications. Conclusion: TCR can be an effective treatment for neck dysphoria. Transoral approach avoids visible neck scars and is not associated with increased peri-operative complications. Further research is needed to determine the long-term outcomes of TCR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hello应助科研通管家采纳,获得10
刚刚
科研通AI5应助科研通管家采纳,获得10
刚刚
JamesPei应助科研通管家采纳,获得10
刚刚
Ava应助科研通管家采纳,获得10
刚刚
1秒前
科研通AI6应助科研通管家采纳,获得10
1秒前
花楹应助科研通管家采纳,获得10
1秒前
1秒前
CipherSage应助科研通管家采纳,获得10
1秒前
SciGPT应助王小西采纳,获得10
1秒前
搜集达人应助科研通管家采纳,获得10
1秒前
Owen应助科研通管家采纳,获得10
1秒前
Owen应助科研通管家采纳,获得10
2秒前
科研通AI6应助科研通管家采纳,获得10
2秒前
2秒前
SciGPT应助科研通管家采纳,获得10
2秒前
FashionBoy应助科研通管家采纳,获得10
2秒前
我是老大应助科研通管家采纳,获得10
2秒前
深情安青应助科研通管家采纳,获得10
2秒前
SciGPT应助科研通管家采纳,获得10
2秒前
希望天下0贩的0应助bingbing采纳,获得30
3秒前
酷酷的傲之完成签到,获得积分10
3秒前
FashionBoy应助科研通管家采纳,获得10
3秒前
3秒前
中平发布了新的文献求助10
4秒前
4秒前
4秒前
流星完成签到,获得积分10
5秒前
5秒前
5秒前
不安青牛应助从心采纳,获得10
6秒前
科研通AI6应助萤火采纳,获得10
6秒前
7秒前
上官若男应助学霸宇大王采纳,获得10
7秒前
7秒前
8秒前
稚晴完成签到,获得积分10
8秒前
古月发布了新的文献求助10
9秒前
李健的小迷弟应助未央采纳,获得10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
줄기세포 생물학 800
Pediatric Injectable Drugs 500
Instant Bonding Epoxy Technology 500
Methodology for the Human Sciences 500
ASHP Injectable Drug Information 2025 Edition 400
DEALKOXYLATION OF β-CYANOPROPIONALDEYHDE DIMETHYL ACETAL 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4384951
求助须知:如何正确求助?哪些是违规求助? 3877937
关于积分的说明 12080577
捐赠科研通 3521425
什么是DOI,文献DOI怎么找? 1932484
邀请新用户注册赠送积分活动 973703
科研通“疑难数据库(出版商)”最低求助积分说明 871939